Literature DB >> 17215050

SeqHepB: a sequence analysis program and relational database system for chronic hepatitis B.

Lilly K W Yuen1, Anna Ayres, Margaret Littlejohn, Danielle Colledge, Andrew Edgely, William J Maskill, Stephen A Locarnini, Angeline Bartholomeusz.   

Abstract

SeqHepB is a combination of a HBV genome sequence analysis program and a relational database that houses data collected from multiple data sources. Registered users can access the sequence analysis component of SeqHepB online for rapid and detailed interrogation of HBV genomic sequences. Its main function is to determine the HBV genotype, identify key mutations associated with antiviral resistance, and identify clinically important HBV mutants. All information generated is uploaded into a database and integrated with patient medical records, pathology laboratory tests, and supplemental virology results such as in vitro drug cross-resistance values. Combined with structured query language (SQL) queries developed in the database, it is possible to extract and correlate clinical, virological, and in vitro phenotypic data rapidly and efficiently. An important component of SeqHepB is its ability to integrate mutations detected within the reverse transcriptase (RT) and locate them onto a three-dimensional (3D) model of the HBV RT that can be viewed at any angle with known antiviral drug molecules in the catalytic pocket of the enzyme. SeqHepB will enable virologists and physicians to individualise patient management, cope with the explosion of antiviral associated HBV mutations, and to conduct cross-sectional retrospective or prospective studies on HBV-infected individuals during therapy.

Entities:  

Mesh:

Year:  2006        PMID: 17215050     DOI: 10.1016/j.antiviral.2006.11.014

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  17 in total

1.  Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery.

Authors:  Soo-Yon Rhee; Severine Margeridon-Thermet; Mindie H Nguyen; Tommy F Liu; Ron M Kagan; Bastian Beggel; Jens Verheyen; Rolf Kaiser; Robert W Shafer
Journal:  Antiviral Res       Date:  2010-09-25       Impact factor: 5.970

2.  Bioinformatic curation and alignment of genotyped hepatitis B virus (HBV) sequence data from the GenBank public database.

Authors:  Trevor G Bell; Mukhlid Yousif; Anna Kramvis
Journal:  Springerplus       Date:  2016-10-28

3.  Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure.

Authors:  Stephen Locarnini
Journal:  Hepatol Int       Date:  2008-03-28       Impact factor: 6.047

Review 4.  Unraveling the web of viroinformatics: computational tools and databases in virus research.

Authors:  Deepak Sharma; Pragya Priyadarshini; Sudhanshu Vrati
Journal:  J Virol       Date:  2014-11-26       Impact factor: 5.103

5.  The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitro.

Authors:  Nadia Warner; Stephen Locarnini; Michael Kuiper; Angeline Bartholomeusz; Anna Ayres; Lilly Yuen; Tim Shaw
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

6.  Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity.

Authors:  Michiko Hyakumura; Renae Walsh; Morten Thaysen-Andersen; Natalie J Kingston; Mylinh La; Louis Lu; George Lovrecz; Nicolle H Packer; Stephen Locarnini; Hans J Netter
Journal:  J Virol       Date:  2015-09-02       Impact factor: 5.103

7.  Evaluation of the Abbott HBV RUO sequencing assay combined with laboratory-modified interpretive software.

Authors:  Jeffrey J Germer; Priya Abraham; Jayawant N Mandrekar; Joseph D C Yao
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948

8.  Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals.

Authors:  Gail V Matthews; Eric Seaberg; Gregory J Dore; Scott Bowden; Sharon R Lewin; Joe Sasadeusz; Pip Marks; Zachary Goodman; Frances H Philp; Yiwei Tang; Stephen Locarnini; Chloe L Thio
Journal:  AIDS       Date:  2009-08-24       Impact factor: 4.177

Review 9.  Molecular testing in the diagnosis and management of chronic hepatitis B.

Authors:  Alexandra Valsamakis
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

10.  Hepatitis B virus genotype A: design of reference sequences for sub-genotypes.

Authors:  Qun Cai; Huilan Zhu; Yafei Zhang; Xu Li; Zhenhua Zhang
Journal:  Virus Genes       Date:  2016-03-22       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.